Literature DB >> 1406043

Treatment failures with multidrug therapy.

D Lobo.   

Abstract

Mesh：

Year:  1992        PMID： 1406043     DOI： 10.5935/0305-7518.19920060

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  4 in total

1.  Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study.

Authors:  Anil Kumar; Anita Girdhar; Bhavneswar Kumar Girdhar
Journal:  BMJ Open       Date:  2012-08-13       Impact factor: 2.692

2.  Low risk of relapse and deformity among leprosy patients who completed multi-drug therapy regimen from 2005 to 2010: A cohort study from four districts in South India.

Authors:  Prabu Rajkumar; Girish Kumar Chethrapilly Purushothaman; Manickam Ponnaiah; Devika Shanmugasundaram; Jayasree Padma; Rang Lal Meena; Selvaraj Vadivoo; Sanjay M Mehendale
Journal:  PLoS Negl Trop Dis       Date:  2021-11-23

Review 3.  Systematic Review of Survival Analysis in Leprosy Studies-Including the Following Outcomes: Relapse, Impairment of Nerve Function, Reactions and Physical Disability.

Authors:  Celivane Cavalcanti Barbosa; Gilberto Silva Nunes Bezerra; Amanda Tavares Xavier; Maria de Fátima Pessoa Militão de Albuquerque; Cristine Vieira do Bonfim; Zulma Maria de Medeiros; Wayner Vieira de Souza
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

4.  Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study.

Authors:  Anil Kumar; Anita Girdhar; B K Girdhar
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.